Annual Report 2007 3-24-08.pdf - Moffitt Cancer Center

Keeping The Momentum Going:
Future Plans Are Aggressive
“It will be exciting to watch as the Donald A. Adam Comprehensive Melanoma Research Center
translates scientific discoveries to the clinic –– all with the aim of beating melanoma,” says Dr. Dalton.
“And we also are committed to the prevention and cure of all forms of cancer. To that end, we are
working to take them down one at a time.”
Moffitt Cancer Center is planning other research centers that will focus on a specific disease or
scientific effort. Now in development are centers devoted to translational research in lung cancer, led
by Gerold Bepler, M.D., Ph.D., leader of Moffitt’s Thoracic Oncology Program, and in drug discovery, led
by Saïd Sebti, Ph.D., leader of the Drug Discovery Program.
“Launching these initiatives to overtake and, one day in the future, eliminate cancer is very aggressive
and expensive and will require the collaboration and financial support of many different people and
various resources,” says Dr. Dalton. “We are seeking support from various organizations and individuals.”
Along with Dr. Dalton, Dr. Weber emphasizes that generous donations of varying amounts –– large
and small –– from multiple sources are needed to continue funding the CMRC and to keep the current
research momentum in steady motion forward.
Part of Moffitt’s Total Cancer
Care/M2Gen initiative that
aims to deliver personalized
cancer care, this new “robotic
freezer” (demonstrated by
Celia Sigua) is an automated
tissue sample and storage
retrieval system. It has a
capacity of thousands of
samples that are stored at
-80 degrees Centigrade
(-112 degrees Fahrenheit).
In studying these samples,
scientists can assimilate
extensive data on
treatment effectiveness.
16 MOFFITT CANCER CENTER